A New Homogeneous Surrogate Virus Neutralization Test Format Based on Liposomes and the Complement System
Analytical Chemistry · 16.11.2026
DOI: 10.1021/acs.analchem.6c04398 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, online erschienen am 16.11.2026. Verfasst von Kilian Hoecherl und 9 weiteren Autor:innen. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bundesministerium f?r Forschung, Technologie und Raumfahrt, Bayerisches Staatsministerium f?r Wissenschaft und Kunst.
Abstract (Originalsprache)
Neutralizing antibodies are key mediators of protection against common viral infections such as SARS-CoV-2, influenza and respiratory syncytial virus (RSV), making them an important target for diagnostic assays assessing immune status and vaccine efficacy. Here we present a novel platform technology that specifically detects SARS-CoV-2 neutralizing antibodies in a simple homogeneous no-wash format as a surrogate virus neutralization test (sVNT). Liposomes loaded with a quenched fluorophore were modified with the angiotensin-converting enzyme 2 (ACE2) receptor, the main receptor for SARS-CoV-2 entry. Virus surrogates based on the receptor binding domain (RBD) of the SARS-CoV-2 spike protein were developed that bind to ACE2-liposomes and contain a trigger moiety, which activates the complement system leading to liposome lysis. Neutralizing antibodies inhibit this binding event and thus prevent the generation of a fluorescent signal. The proof-of-principle was demonstrated using SARS-CoV-2 neutralizing antibodies and pooled human serum, generating IC50 values that can be compared to other assay formats. Testing of 20 SARS-CoV-2 antibody negative sera and 24 sera from individuals with SARS-CoV-2 infection and/or vaccination history, resulted in a specificity of 95%, sensitivity of 96% and a strong correlation (Spearman r = 0.78, Pearson r = 0.77) with antibody titers determined in a pseudovirus neutralization test. The assay platform can be readily adapted to other targets, offering a rapid and straightforward approach to serological immunodiagnostics and in general other competitive assay formats. The simplicity of the assay, the avoidance of washing and immobilization steps renders this format ideally suited for high-throughput screening and point-of-care settings.
Förderung
- Bundesministerium f?r Forschung, Technologie und Raumfahrt
- Bayerisches Staatsministerium f?r Wissenschaft und Kunst
Zitieren
APA
Hoecherl, K., Konrad, J., Einhauser, S., Neckermann, P., Reiner, C., Streif, S., Pauly, D., Wagner, R., Breunig, M., & Baeumner, A. J. (2026). A New Homogeneous Surrogate Virus Neutralization Test Format Based on Liposomes and the Complement System. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.6c04398
Vancouver
Hoecherl K, Konrad J, Einhauser S, Neckermann P, Reiner C, Streif S, et al. A New Homogeneous Surrogate Virus Neutralization Test Format Based on Liposomes and the Complement System. Analytical Chemistry. 2026. doi:10.1021/acs.analchem.6c04398
BibTeX
@article{Hoecherl2026,
author = {Hoecherl, Kilian and Konrad, Johannes and Einhauser, Sebastian and Neckermann, Patrick and Reiner, Christina and Streif, Simon and Pauly, Diana and Wagner, Ralf and Breunig, Miriam and Baeumner, Antje J.},
title = {A New Homogeneous Surrogate Virus Neutralization Test Format Based on Liposomes and the Complement System},
journal = {Analytical Chemistry},
year = {2026},
doi = {10.1021/acs.analchem.6c04398}
}
EUVIMED